Study to Assess Real Life Effectiveness of Foslevodopa/Foscarbidopa in Adult German Participants at Initial Stages of Advanced Parkinson's Disease (EARLY-FOS)
Clinical trial NCT06916507 · RECRUITING
Trial details
- NCT number
- NCT06916507
- Sponsor
- AbbVie
- Status
- RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2025-05-06
- Primary completion
- 2027-09-01
- Enrollment
- 125
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.